Battered insurer MDwise readies for turnaround
The CEO who took charge last summer of the Indianapolis company that provides health insurance, food, career help and other services to low-income people acknowledges he has a big job ahead.
View ArticleLilly bets billions on focus on cancer drugs
Long a leader in diabetes and neuroscience drugs, Eli Lilly and Co. is pushing hard and spending record sums to turbocharge its oncology business, potentially a huge growth area.
View ArticleLilly creates public downtown park on edge of its headquarters campus
The city's newest park is springing up on the south side of downtown, a district quickly filling up with apartments, offices and retail—and a noticeable shortage of public green space.
View ArticleRecently launched research institute pursuing life science innovations...
Backed by more than $100 million in funding from Indiana companies and foundations, the Indiana Biosciences Research Institute has hired 39 employees and hopes to ramp up to 80 within another three years.
View ArticleQuestions loom over proposed Carmel rehabilitation hospital
Two out-of-state companies that want to build a 60-bed hospital in Carmel have a history of mass layoffs, at least one high-profile bankruptcy, and accusations of kickbacks and billing irregularities.
View ArticleLilly's push into pain research starting to pay off
In recent months, the drugmaker has won federal approval to sell a drug called Emgality for two conditions: migraine pain and cluster headaches.
View ArticleDebunking medical myths all in a day’s work for IU's Dr. Aaron Carroll
Carroll uses Twitter, a New York Times column, blog post, podcast, videos and books to publish his findings on just about any health issue he thinks needs explaining or correcting.
View Article
